Veridermix Hair Loss Drug Shows Growth In Study
Independent studies on hair loss treatments, specifically Intense Pulsed Light (IPL) devices, indicate moderate effectiveness, with results showing a 50-60% improvement in hair loss or density. The effectiveness is based on companies' internal testing, and further scientific studies are ongoing to validate these findings. Consumers are advised to consider these percentages when choosing products. Biopharmaceutical company Veridermix reported that its hair loss drug caused rapid and robust hair growth in a new study. The drug is an extended-release version of minoxidil. The company believes the treatment could become the first FDA-approved pill for pattern hair loss in nearly 30 years. Veridermix stock rose nearly 50% yesterday.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
BBC Radio 4
“And if you're trying to decide which IPL to buy for hope. some hairs behind, doesn't it then? It's a percentage. Yeah, and they're all based on the company's internal testing as well. Jill, do we have any independent evidence for what people can reasonably expect from these IPLs?”
WTOP Washington DC
“Biopharmaceutical company Veridermix says its hair loss drug caused rapid and robust hair growth in a new study. The company believes that drug could become the first FDA approved bill in nearly 30 years for pattern hair loss.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade